Piramal Pharma Ltd share price
Piramal Pharma Ltd (PPLPHARMA) is a stock listed on India's exchanges (NSE & BSE). On Traddx you can view its live price, interactive candlestick charts with 20/50/200-day moving averages and golden/death-cross detection, quarterly results, analyst price targets, peer comparison, and the smart-money signal โ which star investors hold it and who is buying it on today's bulk/block deals tape.
Piramal Pharma Limited value chain โ customers, suppliers & competitors
Piramal Pharma Limited is a pharmaceutical company operating in contract development and manufacturing (CDMO), complex hospital generics, and consumer healthcare products. It sits between chemical and raw material providers and global healthcare providers, hospitals, and end consumers.
๐ Customers โ who buys from Piramal Pharma Limited
- Global Pharmaceutical Companies โ Contract development and manufacturing services (CDMO)
- Hospitals and Healthcare Institutions โ Complex hospital generics and critical care products
- Retail Consumers โ Over-the-counter (OTC) consumer healthcare products
โ๏ธ Suppliers โ raw materials & inputs
- Global Specialty Chemical Suppliers โ Active pharmaceutical ingredients and chemical intermediates
- Packaging Material Vendors โ Vials, bottles, and blister packs for generics and consumer products
โ๏ธ Competitors โ other sellers
- Lupin Limited โ Competes in generic pharmaceuticals and formulations, larger in scale.
- Gland Pharma Limited โ Competes directly in injectable and contract manufacturing segments.
- GlaxoSmithKline Pharmaceuticals โ Competes in consumer healthcare and established pharma brands.
๐ Other suppliers to its customers
- Divi's Laboratories โ Alternative CDMO and API partner for global pharma clients
- Lonza Group โ Global CDMO major competing for international client contracts
๐ค Peers that share its suppliers
- Sun Pharmaceutical Industries โ Shares similar raw material and chemical supply chains in India
- Dr. Reddy's Laboratories โ Procures comparable specialty chemicals and intermediates
This value-chain map is AI-researched from public sources; company links and any figures are estimates, not official company disclosures. Not investment advice.